Skip to content
10-Q

Quarterly Report

BIOSYNERGY INC

0001437749-21-022107

← back to feed
Filed
Sep 14, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · Jul 31, 2021 14.94M sh
Operating Cash Flow Q1 2022 · Jul 31, 2021 $46.59K
Operating Cash Flow Q1 2022 · Jul 31, 2020 $9.45K
Stockholders Equity Q1 2022 · Jul 31, 2021 $1.65M
Stockholders Equity Q1 2022 · Apr 30, 2021 $1.74M
Current Liabilities Q1 2022 · Jul 31, 2021 $114.17K
Current Liabilities Q1 2022 · Apr 30, 2021 $127.53K
Current Assets Q1 2022 · Jul 31, 2021 $1.59M
Current Assets Q1 2022 · Apr 30, 2021 $1.69M
Total Assets Q1 2022 · Jul 31, 2021 $1.76M
Total Assets Q1 2022 · Apr 30, 2021 $1.89M
Sga Expense Q1 2022 · Jul 31, 2021 $131.79K
Sga Expense Q1 2022 · Jul 31, 2020 $113.54K
Rd Expense Q1 2022 · Jul 31, 2021 $29.27K
Rd Expense Q1 2022 · Jul 31, 2020 $40.05K
Net Income Q1 2022 · Jul 31, 2021 −$88.61K
Net Income Q1 2022 · Jul 31, 2020 −$13.22K
Operating Income Q1 2022 · Jul 31, 2021 −$125.25K
Operating Income Q1 2022 · Jul 31, 2020 −$19.11K
Gross Profit Q1 2022 · Jul 31, 2021 $69.93K
Gross Profit Q1 2022 · Jul 31, 2020 $179.57K
Cost Of Revenue Q1 2022 · Jul 31, 2021 $104.91K
Cost Of Revenue Q1 2022 · Jul 31, 2020 $111.88K